Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed May 12, 2017
Insider Transaction Report
Form 4
thrasher francis martin
Director
Transactions
- Award
Common Shares, without par value
2017-05-11+7,500→ 19,365 total - Award
Director Option (right to buy)
2017-05-11+15,000→ 15,000 totalExercise: $1.56Exp: 2027-05-11→ Common Shares, without par value (15,000 underlying)
Holdings
- 272,813(indirect: By 2089636 Ontario Ltd.)
Common Shares, without par value
Footnotes (4)
- [F1]Restricted Stock Units, all of which vest on May 11, 2018, subject to the director's continued service on the Board as of such date. Vested shares will be delivered to the Reporting Person on the earlier of the date that the Reporting Person ceases to provide services to the Board and the date of a Change of Control, as defined in the Issuer's 2016 Amended and Restated Long-Term Incentive Plan, in either case provided that the Restricted Stock Units are vested on such date.
- [F2]Includes 11,865 shares of Common Stock and 7,500 Restricted Stock Units.
- [F3]The Reporting Person is the sole owner and president of 2089636 Ontario Ltd.
- [F4]The option vests in one installment on May 11, 2018, subject to the director's continued service on the Board as of such date.